Riskpilot← Back to searchSign inGet full accessBiocell Aktiebolag
ABActiveOrg 5561664342Bengt Färjares Väg 3 Lgh 1302Activities of holding companies · NACE 6421Est. 19720 employees
Revenue 2025
SEK 0
EBITDA margin
—
Equity ratio
88.5%
Financial strength
Net profit 2025
SEK -370K
0 employees
| Revenue | SEK 0 | — |
| EBITDA | SEK -662K | — |
| Net profit | SEK -370K | — |
| Total assets | SEK 13,1M | — |
| Equity | SEK 11,6M | — |
| Employees | 0 | — |
Legal name
Biocell Aktiebolag
Org number
5561664342
Legal form
Aktiebolag
NACE code
6421 · Activities of holding companies
Founded
4 juli 1972
Share capital
SEK 1 000 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget ska äga och förvalta fast och lös egendom, bedriva rådgivning inom angivna kompetensområden samt bedriva därmed förenlig verksamhet. Bolaget skall dock inte bedriva sådan verksamhet som avses i bankrörelselagen eller lagen om finansieringsverksamhet.
Address
Bengt Färjares Väg 3 Lgh 1302
Phone
+4686113331
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 38 296 | 0 | 0 | — | 0 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 4 991 | −663 | −716 | 0 | −662 |
| Depreciation & amort. | −5 | −0 | −0 | — | −13 |
| EBIT | 4 986 | −663 | −716 | 0 | −675 |
| Net financials | 5 524 | 1 856 | 822 | — | 389 |
| Profit before tax | 10 511 | 1 194 | 106 | 0 | −288 |
| Tax | −920 | −412 | −274 | — | −82 |
| Net profit | 9 591 | 782 | −168 | — | −370 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 16 221 | 15 569 | 14 373 | — | 13 146 |
| Equity | 11 823 | 12 605 | 12 437 | — | 11 633 |
| Long-term debt | 0 | 0 | 0 | — | 0 |
| Short-term debt | 4 397 | 2 964 | 1 936 | — | 1 514 |
| Total debt | 4 397 | 2 964 | 1 936 | — | 1 514 |
EBITDA margin
-66200000.0%
This company
15.8%
Market median
-418987442% vs market
20212025
Equity ratio
88.5%
This company
38.2%
Market median
+132% vs market
20212025
Return on equity
-3.2%
This company
18.4%
Market median
-117% vs market
20212025
Net profit margin
-37000000.0%
This company
8.1%
Market median
-456790223% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.13×
This company
0.62×
Market median
+79% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biocell Aktiebolag also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Hans Bruno Samuel Niklasson | Board of Directors | 0 companies |
| Oscar Jacob Cecil Niklasson | Deputy Board Member | 0 companies |